Rameditech Co., Ltd. announced on the 4th that it participated in 'Arab Health 2025', a medical equipment exhibition for the Middle East and North Africa held at the Dubai World Trade Center in the United Arab Emirates (UAE) for four days from January 27th to the 30th.
'Arab Health 2025' is the largest medical device exhibition targeting the Middle East and North Africa (MENA) region, and this year, approximately 3,400 companies from 180 countries participated. The exhibition is gradually expanding in scale with buyers from Middle Eastern countries such as Saudi Arabia, Dubai, Qatar, and Iran, as well as European countries. In particular, Saudi Arabia is promoting the 'Healthcare Sandbox' project for healthcare and digital innovation as part of its 'Vision 2030' national strategy, and Dubai, UAE, is also promoting the medical device and pharmaceutical industries as important fields in its 'Industrial Strategy 2030'.
RamediTech participated in this exhibition together with global medical equipment and pharmaceutical companies such as GE, Johnson & Johnson, and Medtronic, and showcased ▲'HandyRay Glu' ▲'PURAXEL SERIES' ultra-small fractional laser ▲'CareVeam' UVB wavelength laser light therapy device for diabetic patients. In particular, 'HandyRay Glu' performs needle-free laser blood collection and blood sugar measurement simultaneously, and supports convenient blood sugar management for diabetic patients by linking the measurement data to a mobile app in real time. In addition, 'CareVeam' is a laser light therapy device for vitiligo and psoriasis, and received superior evaluations for performance and price compared to existing products of other companies.
At this exhibition, Lameditech conducted export consultations with 130 companies from over 30 countries and signed distribution contracts for medical devices and consumables with distributors in many Middle Eastern countries. In addition, it is discussing cooperation with large distributors in the Gulf region and Africa and plans to sign regional sales contracts for the 'HandyRay Series' and phototherapy devices.
Choi Jong-seok, CEO of LamediTech, said, “We are aiming for 2025 to be the first year of expansion in the global medical device market, and through this exhibition, we hope to lay the foundation for advancing into the Middle East, North Africa, and Southeast Asia markets, and to lay the foundation for publicizing the innovativeness of K-healthcare.” He added, “We will solidify our position as a leading global healthcare company within the next five years through new products that are currently in the process of obtaining CE and FDA certification.”
- See more related articles
You must be logged in to post a comment.